Array BioPharma to be acquired by drug giant Pfizer for $11.4B
BOULDER -- Drug manufacturing giantPfizer and Array BioPharma today announced they have entered into a definitive merger agreement under which Pfizer will acquire Array, a Boulder-based... Read More
Monday June 17, 2019
Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care
BOULDER -- Array BioPharma Inc. (NASDAQ: ARRY) announced the National Comprehensive Cancer Network(NCCN) has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to... Read More
Tuesday March 19, 2019
European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment
BOULDER -- Array BioPharma Inc . (NASDAQ: ARRY) today announced the European Commission (EC) has approved BRAFTOVI (encorafenib) in combination with MEKTOVI (binimetinib) for the treatment of... Read More
Friday September 21, 2018
Array BioPharma names Carrie S. Cox chair of its board of directors
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced Carrie S. Cox has been named chair of its board of directors effective immediately. Cox has been appointed to the Audit and... Read More
Tuesday August 14, 2018
Array BioPharma: European Medicines Agency recommends approval of melanoma cancer drug
BOULDER -- Array BioPharma Inc. (NASDAQ: ARRY) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending... Read More
Monday July 30, 2018
Array BioPharma: National Comprehensive Cancer Network, FDA OKs drug combo for melanoma
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) announced that the National Comprehensive Cancer Network (NCCN) has updated the Clinical Practice Guidelines in Oncology for Melanoma to include... Read More
Monday July 16, 2018
Array BioPharma announces FDA approval of encorafenib and binimetinib cancer drugs
BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) announced the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI(encorafenib) capsules in combination with MEKTOVI(binimetinib)tablets... Read More
Thursday June 28, 2018
Array BioPharma to collaborate with Pfizer on clinical drug trials
BOULDER -- Array BioPharma (Nasdaq: ARRY) today announced it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel... Read More
Tuesday December 19, 2017
IN Sponsors
Browse
Entrepreneurial by Nature
